Epidemiology of Systemic Lupus Erythematosus in Rural Wisconsin
Overview
Affiliations
We investigated the epidemiology of systemic lupus erythematosus (SLE) in the Marshfield Epidemiologic Study Area (MESA), a defined rural region where nearly all residents obtain their health care from a large clinic system. Computerized medical records were searched to identify MESA residents diagnosed with SLE from 1991 through 2001. Medical records were manually reviewed for all selected patients to identify cases of SLE using the 1982 revised American College of Rheumatology criteria. Patients with > or = 4 criteria were classified as definite SLE. Age- and gender-specific SLE incidence rates (1991-2001), the population prevalence rate of SLE on 31 December 2001 and survival rates were calculated. We identified 117 MESA residents with definite SLE. The average age-adjusted incidence of definite SLE was 5.1 per 100 000 per year (95% CI: 3.6, 6.6) and the age-adjusted population prevalence was 78.5 per 100 000 (95% CI: 59.0, 98.0). The mean age at diagnosis among the 44 incident cases was 51.7 years (range: 14-90 years). Positive anti-nuclear antibody (ANA), hematologic abnormalities, arthritis and renal disease were common at diagnosis. Five- and 10-year survival rates were 88% and 76%, respectively. Epidemiologic characteristics of SLE in this rural Caucasian population are generally similar to those reported by other US studies. One notable difference is a relatively high incidence of SLE in older adults.
Rheumatologic diseases in patients with inborn errors of immunity in the USIDNET registry.
Padem N, Wright H, Fuleihan R, Garabedian E, Suez D, Cunningham-Rundles C Clin Rheumatol. 2022; 41(7):2197-2203.
PMID: 35099673 DOI: 10.1007/s10067-021-06044-4.
Long-Term Outcome in Systemic Lupus Erythematosus; Knowledge from Population-Based Cohorts.
Moe S, Haukeland H, Molberg O, Lerang K J Clin Med. 2021; 10(19).
PMID: 34640322 PMC: 8509465. DOI: 10.3390/jcm10194306.
Disparities in Lupus and Lupus Nephritis Care and Outcomes Among US Medicaid Beneficiaries.
Pryor K, Barbhaiya M, Costenbader K, Feldman C Rheum Dis Clin North Am. 2021; 47(1):41-53.
PMID: 34042053 PMC: 8171807. DOI: 10.1016/j.rdc.2020.09.004.
Falasinnu T, Chaichian Y, Palaniappan L, Simard J ACR Open Rheumatol. 2019; 1(3):164-172.
PMID: 31777791 PMC: 6858029. DOI: 10.1002/acr2.1024.
Bae E, Lim S, Han K, Jung J, Choi H, Kim H Korean J Intern Med. 2019; 35(3):652-661.
PMID: 31212409 PMC: 7214355. DOI: 10.3904/kjim.2018.303.